Astrazeneca To Bring Innovative Medicines Faster To India Says Md Panchal

67 days 👁 11

The company reported a robust set of numbers for the December quarter of FY25, with its profit nearly doubling year-on-year to ?30.8 crore and its Ebitda margin expanding sharply from 4.9% to 17.5%. Its revenues grew 44% to ?440.3 crore.

Click Here To Visit Source

Recommended For You

UP govt targets 12 pc increase in Kharif productio

Neo Wealth Management appoints Shajikumar Devakar

PNB takes aim at 3-4 specific sectors as it gears

Banking for minors: A progress whose time has come

Should you register for GST Here's everything you

Donald Trump to tether US drug costs to cheapest p

Investment word of the day: Total expense ratio -

Circular economy: What Hyderabad can teach the res

Nissan Layoffs: Carmaker to cut 20,000 jobs global

Worst is over; specialty chemicals, new products t

Bharti Airtel Q4 preview: Low-margin business exit

TCS leases 630,000 sq.ft. in Chennai amid slow IT

Astrazeneca To Bring Innovative Medicines Faster To India, Says Md Panchal